Soligenix News | finanzen.ch

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

03.05.17	Soligenix Receives FDA Protocol Clearance of Pivotal Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients (PR Newswire)
20.04.17	Gainers & Losers Of Apr.19: SNGX, IMGN, CBLI, SSH, AKTX... (RTTNews)
12.04.17	Soligenix to Present at the World Orphan Drug Congress (PR Newswire)
27.03.17	Soligenix Announces Recent Accomplishments And Year-End 2016 Financial Results (PR Newswire)
15.03.17	Soligenix to Present Data on Dusquetide in Combating Antibiotic-Resistant Infections at the 19th Annual Superbugs & Superdrugs Conference (PR Newswire)
10.03.17	Soligenix to Present Results from its Ricin Toxin Vaccine Program at the Society of Toxicology 56th Annual Meeting (PR Newswire)
22.02.17	Soligenix Receives European Patent for Formulation of Synthetic Hypericin to Treat Psoriasis (PR Newswire)
02.02.17	Soligenix Announces SGX301 Receives Promising Innovative Medicine Designation from the UK Medicines and Healthcare Products Regulatory Agency (PR Newswire)
05.01.17	Soligenix Receives Positive Scientific Advice from the European Medicines Agency for SGX942 in the Treatment of Oral Mucositis in Head and Neck Cancer Patients (PR Newswire)
03.01.17	Soligenix Announces Extension of Development Agreement with Emergent BioSolutions (PR Newswire)
20.12.16	Soligenix Advances Collaboration with IDT Biologika (PR Newswire)
16.12.16	Soligenix Announces Closing of Public Offering (PR Newswire)
12.12.16	Soligenix Announces SGX942 Receives Promising Innovative Medicine Designation from the UK Medicines and Healthcare Products Regulatory Agency (PR Newswire)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Geberit	511.80	3.46 %	K V
Logitech Intl	80.84	2.10 %	K V
UBS Group	29.99	2.08 %	K V
Sika	221.90	1.42 %	K V
Sonova Hldg	304.30	1.30 %	K V
Roche Hldg G	264.40	0.38 %	K V
Novartis	90.42	0.34 %	K V
Alcon	75.86	0.21 %	K V
CieFinRichemont	139.75	-0.32 %	K V
Nestle	73.56	-0.81 %	K V